98 related articles for article (PubMed ID: 23329570)
1. Vascular endothelial growth factor--marker for proliferation in thyroid diseases?
Malkomes P; Oppermann E; Bechstein WO; Holzer K
Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):6-13. PubMed ID: 23329570
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
Jebreel A; England J; Bedford K; Murphy J; Karsai L; Atkin S
Int J Exp Pathol; 2007 Aug; 88(4):271-7. PubMed ID: 17696908
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical profile of angiogenesis in the thyroid gland in various thyroid diseases].
Rurua NZ; Gogiashvili LE; Tsagareli ZG
Georgian Med News; 2013 Dec; (225):97-104. PubMed ID: 24423685
[TBL] [Abstract][Full Text] [Related]
4. Significantly high expression of platelet-derived growth factor (PDGF) in benign nodules of the thyroid: relevance in the development of goitre recurrence?
Malkomes P; Oppermann E; Bechstein WO; Holzer K
Langenbecks Arch Surg; 2011 Dec; 396(8):1165-72. PubMed ID: 21553231
[TBL] [Abstract][Full Text] [Related]
5. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
Nagura S; Katoh R; Miyagi E; Shibuya M; Kawaoi A
Hum Pathol; 2001 Jan; 32(1):10-7. PubMed ID: 11172289
[TBL] [Abstract][Full Text] [Related]
7. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.
Sato K; Yamazaki K; Shizume K; Kanaji Y; Obara T; Ohsumi K; Demura H; Yamaguchi S; Shibuya M
J Clin Invest; 1995 Sep; 96(3):1295-302. PubMed ID: 7657804
[TBL] [Abstract][Full Text] [Related]
8. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.
Kebebew E; Peng M; Treseler PA; Clark OH; Duh QY; Ginzinger D; Miner R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6105-11. PubMed ID: 15579766
[TBL] [Abstract][Full Text] [Related]
9. Expression of estrogen and progesterone receptors and Ki-67 antigen in Graves' disease and nodular goiter.
Domoslawski P; Podhorska-Okolow M; Pula B; Lukienczuk T; Dziegiel P
Folia Histochem Cytobiol; 2013; 51(2):135-40. PubMed ID: 23907943
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucocorticoids and oestrogen on interleukin-6 production by human thyrocytes from patients with Graves' disease and toxic multinodular goitre and from HTori3 cells.
Jones TH; Kennedy RL; Justice SK; Davies R
Eur J Endocrinol; 1997 Oct; 137(4):429-32. PubMed ID: 9368513
[TBL] [Abstract][Full Text] [Related]
11. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
[TBL] [Abstract][Full Text] [Related]
12. Expression of thioredoxin in patients with Graves' disease.
Kihara M; Kontani K; Yamauchi A; Miyauchi A; Nakamura H; Yodoi J; Yokomise H
Int J Mol Med; 2005 May; 15(5):795-9. PubMed ID: 15806300
[TBL] [Abstract][Full Text] [Related]
13. Role of basic fibroblast growth factor in the pathogenesis of nodular goiter.
Gärtner R; Veitenhansl M; Aktas J; Schopohl D
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():36-8. PubMed ID: 8980998
[TBL] [Abstract][Full Text] [Related]
14. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
[TBL] [Abstract][Full Text] [Related]
15. The presence of adenosine A2a receptor in thyrocytes and its involvement in Graves' IgG-induced VEGF expression.
Zhang L; Xu J; Sun N; Cai H; Ren M; Zhang J; Yu C; Wang Z; Gao L; Zhao J
Endocrinology; 2013 Dec; 154(12):4927-38. PubMed ID: 24080368
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations.
Celano M; Sponziello M; Tallini G; Maggisano V; Bruno R; Dima M; Di Oto E; Redler A; Durante C; Sacco R; Filetti S; Russo D
Endocrine; 2013 Feb; 43(1):147-53. PubMed ID: 22815044
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia.
Thompson SD; Franklyn JA; Watkinson JC; Verhaeg JM; Sheppard MC; Eggo MC
J Clin Endocrinol Metab; 1998 Apr; 83(4):1336-41. PubMed ID: 9543164
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C
Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissues.
Tanaka K; Kurebayashi J; Sonoo H; Otsuki T; Yamamoto Y; Ohkubo S; Yamamoto S; Shimozuma K
Surg Today; 2002; 32(9):761-8. PubMed ID: 12203051
[TBL] [Abstract][Full Text] [Related]
20. T3-release from autonomously functioning thyroid nodules in vitro.
Poertl S; Kirner J; Saller B; Mann K; Hoermann R
Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
